| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |